NASDAQ:AVR - Nasdaq - US03675P1021 - Common Stock - Currency: USD
4.98
-0.16 (-3.11%)
The current stock price of AVR is 4.98 USD. In the past month the price increased by 18.43%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
SYK | STRYKER CORP | 29.95 | 139.34B | ||
MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.25 | 44.70B | ||
IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
RMD | RESMED INC | 25.98 | 34.64B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
DXCM | DEXCOM INC | 43.43 | 28.10B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.84 | 23.53B |
Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. The company is headquartered in Eagan, Minnesota and currently employs 136 full-time employees. The company went IPO on 2024-12-13. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.
ANTERIS TECHNOLOGIES GLOBAL
860 Blue Gentian Road, Suite 340
Eagan MINNESOTA US
Employees: 136
Company Website: http://www.anteristech.com
Investor Relations: http://anteristech.com/investors/financials.html
Phone: 16514930606
The current stock price of AVR is 4.98 USD. The price decreased by -3.11% in the last trading session.
The exchange symbol of ANTERIS TECHNOLOGIES GLOBAL is AVR and it is listed on the Nasdaq exchange.
AVR stock is listed on the Nasdaq exchange.
8 analysts have analysed AVR and the average price target is 16.83 USD. This implies a price increase of 237.95% is expected in the next year compared to the current price of 4.98. Check the ANTERIS TECHNOLOGIES GLOBAL stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ANTERIS TECHNOLOGIES GLOBAL (AVR) has a market capitalization of 179.38M USD. This makes AVR a Micro Cap stock.
ANTERIS TECHNOLOGIES GLOBAL (AVR) currently has 136 employees.
ANTERIS TECHNOLOGIES GLOBAL (AVR) has a resistance level at 5.15. Check the full technical report for a detailed analysis of AVR support and resistance levels.
The Revenue of ANTERIS TECHNOLOGIES GLOBAL (AVR) is expected to grow by 8.02% in the next year. Check the estimates tab for more information on the AVR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AVR does not pay a dividend.
ANTERIS TECHNOLOGIES GLOBAL (AVR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.28).
The outstanding short interest for ANTERIS TECHNOLOGIES GLOBAL (AVR) is 1.59% of its float. Check the ownership tab for more information on the AVR short interest.
ChartMill assigns a technical rating of 3 / 10 to AVR.
ChartMill assigns a fundamental rating of 1 / 10 to AVR. AVR may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AVR reported a non-GAAP Earnings per Share(EPS) of -1.28. The EPS decreased by -50.58% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -218.09% | ||
ROE | -1461.24% | ||
Debt/Equity | 0.02 |
ChartMill assigns a Buy % Consensus number of 80% to AVR. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -130.32% and a revenue growth 8.02% for AVR